Cite
HARVARD Citation
Hartmann, S. et al. (2018). Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer. Journal of cranio-maxillofacial surgery. 46 (3), pp. 492-497. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hartmann, S. et al. (2018). Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer. Journal of cranio-maxillofacial surgery. 46 (3), pp. 492-497. [Online].